Digoxin-like immunoreactive substances in hypertrophic cardiomyopathy.
Mahon
N
N
Mckenna
W J
WJ
D015415:Biomarkers; D002298:Cardenolides; D002312:Cardiomyopathy, Hypertrophic / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D004077:Digoxin; D004791:Enzyme Inhibitors / Q000276:immunology / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D009200:Myocardial Contraction; D009206:Myocardium / Q000378:metabolism / Q000648:ultrastructure; D011379:Prognosis; D012503:Saponins / Q000276:immunology / Q000378:metabolism*; D012518:Sarcomeres / Q000378:metabolism / Q000648:ultrastructure; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D017725:Ventricular Pressure
D015415:Biomarkers; D002298:Cardenolides; D004791:Enzyme Inhibitors; D012503:Saponins; C034504:digoxin-like factors; D004077:Digoxin; D000254:Sodium-Potassium-Exchanging ATPase